2,388
Views
0
CrossRef citations to date
0
Altmetric
Drug Evaluation

Elinzanetant: a phase III therapy for postmenopausal patients with vasomotor symptoms

&
Pages 19-26 | Received 19 Oct 2023, Accepted 10 Jan 2024, Published online: 25 Jan 2024